Retatrutide 120mg Pre-Filled Pen Once-Weekly Injection for Chronic Weight Management Retatrutide 120mg Pre-Filled Pen is an investigational peptide-based injectable therapy designed to support chronic weight management in adults with obesity or overweight when used alongside a reduced-calorie diet and regular physical activity
Safety Profile and Drug Interactions Known Adverse Effects at Standard Doses At 100 to 300 mcg per injection in patients without liver disease, the most common adverse effects are transient injection-site reactions, water retention (typically 1 to 2 kg in the first 2 to 4 weeks), and mild carpal tunnel symptoms
This personalized approach allows for optimal results that are specific to each patients unique body type and desired outcome
GLP-1 receptor agonists typically increase resting heart rate by 2-4 beats per minute on average, though some patients experience increases of 10 beats per minute or more
Far less attention has been given to what comes next
CoreAge Rx provides dosing options of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg, administered as a weekly injection